Severe hemolytic anemia, leukemoid reaction, acidosis, hypokalemia, and transient hepatitis associated with the administration of ritodrine hydrochloride (Yutopar).
D000138:Acidosis / Q000139:chemically induced; D000743:Anemia, Hemolytic / Q000139:chemically induced*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D005260:Female; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced*; D007231:Infant, Newborn; D007955:Leukemoid Reaction / Q000139:chemically induced; D008111:Liver Function Tests; D008297:Male; D007752:Obstetric Labor, Premature / Q000188:drug therapy; D011247:Pregnancy; D011412:Propanolamines / Q000009:adverse effects*; D012312:Ritodrine / Q000009:adverse effects*
D011412:Propanolamines; D012312:Ritodrine